About Us

Ponya Therapeutics is an FDA-registered, cGTP, and GMP-compliant biotechnology company headquartered in Atlanta, Georgia. Ponya is dedicated to advancing the field of regenerative medicine through design, development, and production of human tissue-derived allograft products. All donated tissue utilized in Ponya’s products is tested in accordance with applicable federal regulations, and affiliated tissue recovery agencies are FDA-registered and operate in accordance with AATB standards.

Mission

Ponya Therapeutics’ mission is to advance the field of regenerative medicine through the design, development, and manufacturing of human tissue-derived allografts. Guided by rigorous quality systems and regulatory compliance, Ponya ensures safety, traceability, and product reliability; transforming every donor’s generous contribution into trusted solutions that support providers, partners, and patient outcomes.

Vision

To unlock access to regenerative medicine through innovation, quality, and scale. Science-Driven, Safety-Focused, Patient-First

Core Values

Precision

We uphold uncompromising rigor and attention to detail across our Clinical Laboratory, Therapeutics, and Investment divisions. Delivering accurate, reliable solutions that directly impact patient outcomes.

Openness

We operate with transparency, collaboration, and inclusivity, integrating science, technology, and human insight across all divisions to move healthcare forward together.

Innovation

We drive bold, forward-thinking solutions, advancing regenerative medicine, enhancing capabilities, and redefining compliance standards.

Accessibility

We expand equitable access to high-quality diagnostics, advanced therapeutics, and expert guidance ensuring meaningful impact across patients, providers, and communities.